Inventor
Noora Salovuori
Inventor
Helsinki, FI
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
C12NMicroorganisms or enzymes27%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture27%
Y02PClimate change mitigation technologies in the production or processing of goods20%
PatentTitleYear
10,731,168Protease deficient filamentous fungal cells and methods of use thereof202010,240,159Protease deficient filamentous fungal cells and methods of use thereof20199,695,454'Production of fucosylated glycoproteins'20179,567,596'Protease deficient filamentous fungal cells and methods of use thereof'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2020Patents assigned to GLYKOS FINLAND OY (4)· patent assignee history
2017Patents assigned to NOVARTIS AG (2)· patent assignee history
2017–2020Based in Helsinki, FI· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GLYKOS FINLAND OY | 4 | 2017–2020 |
| NOVARTIS AG | 2 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Helsinki, FI | 4 | 2017–2020 |